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Summary. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is a multifunctional housekeeping protein reported to
be a target of several covalent modifications in many organisms. In a previous study, enterohemorrhagic (EHEC) and
enteropathogenic (EPEC) Escherichia coli strains were shown to secrete GAPDH and the protein to bind human plasmino-
gen and fibrinogen. Here we report that GAPDH of these pathogens is ADP-ribosylated either in the cytoplasm or in the extra-
cellular medium. GAPDH catalyzes its own modification, which involves Cys-149 at the active site. ADP-ribosylation of
extracellular GAPDH may play an important role in the host-pathogen interaction, as also proposed in other pathogens. [Int
Microbiol 2009; 12(3):187-192]
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Introduction
Several cytoplasmic housekeeping enzymes with no detect-
able secretion and retention signal are present on the surface
of microbial pathogens, where they perform functions relat-
ed to the adhesion and/or virulence of the pathogen [13].
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH; EC
1.2.1.12) is among these secreted proteins that interact with
different host components [14,19]. In gram-negative bacte-
ria, the extracellular location of GAPDH in enterohemor-
rhagic (EHEC) and enteropathogenic (EPEC) Escherichia
coli strains was reported by our group [5]. This protein is
secreted into the medium in a soluble and active form and is
also found on the cell surface of these pathogens. E. coli
GAPDH binds human plasminogen and fibrinogen and
remains associated with colon epithelial Caco-2 cells after
the adhesion of EHEC or EPEC [5].
In many organisms, GAPDH can be a target of several
covalent modifications including glutathionylation, S-nitro-
sylation, binding of nitrated fatty acids, phosphorylation, and
ADP-ribosylation [2–4,16]. Most of these modifications are
linked to oxidative stress responses and may be crucial for
proper adaptation to conditions of oxygen stress [3,16,17].
ADP-ribosylation is a reversible, post-translational, covalent
modification of proteins in which the ADP-ribose moiety of
NAD+ is enzymatically transferred to specific amino acid
residues (His, Arg, or Cys) of the target protein, with the sub-
sequent release of nicotinamide [7,10,20]. This modification
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regulates protein function and affects many biological
processes. For instance, in Entamoeba histolytica or group A
streptococci ADP-ribosylation of secreted GAPDH has been
implicated in the interaction of these pathogens with the host
[1,15]. Here, we provide the first report of covalent modifi-
cation of GAPDH by ADP-ribosylation in gram-negative
bacteria. 
Materials and methods
Growth conditions. Bacterial cells were routinely grown at 37°C in
Luria-Bertani (LB) broth. The gapA mutant strain W3CG was grown in min-
imal medium supplemented with malate and glycerol as the carbon source
[6]. Where indicated, cells were grown without shaking at 37°C in
Dulbecco’s modified Eagle’s medium (DMEM) (Gibco) in a CO2 incubator.
Growth was monitored by measuring the optical density at 600 nm (OD600).
When required, tetracycline (12.5 μg/ml) or ampicillin (100 μg/ml) was
added to the medium.
Preparation of cell extracts and isolation of secreted pro-
teins in culture medium. Overnight cultures in LB were diluted 1:50
in the indicated culture media and incubated without shaking at 37°C in a
5% CO2 atmosphere. The bacteria were collected by centrifugation (5000 ×g,
10 min, 4°C) and resuspended in appropriate buffer. After sonic disruption
on ice, cell debris was removed by centrifugation at 16,000 ×g for 30 min at
4°C. The protein concentration of the cell extract was determined by the
method of Lowry [11]. Secreted proteins were isolated by filtering the cul-
ture supernatant through a 0.22-μm pore size filter (Millipore), and the pro-
teins in the filtrate were precipitated by incubation on ice for at least 1 h with
10% trichloroacetic acid (TCA). The protein pellet was washed in 90% (v/v)
ice-cold acetone, air-dried, and suspended in loading buffer before being
resolved by SDS-PAGE [8]. For ADP-ribosylation assays, the secreted pro-
teins were concentrated from 100 ml of the filtrated supernatant by 95%
ammonium sulfate precipitation. The protein pellets were resuspended in 0.5
ml of 100 mM Tris-HCl (pH 7.5) containing 1 mM dithiothreitol (DTT) and
then dialyzed overnight against the same buffer.
Purification of recombinant GAPDH. Recombinant GAPDH was
expressed and purified using the glutathione-S-transferase (GST) gene
fusion system with recognition sites for factor Xa cleavage, as described in
detail previously [5]. 
ADP-ribosylation assays. The ADP-ribosylation reaction mixtures
(100 μl) contained: 100 mM Tris-HCl, (pH 7.5), 1 mM DTT, 0.5 mM ATP,
2 mM MgCl2, 80 μM E-64, 2 μM NAD+ plus 2 μCi [32P]NAD+ (51
mCi/mmol), and protein sample (75 μg secreted proteins or 200 μg cell
extracts) as the source of both enzyme and substrate(s). When indicated,
reactions were done with 10 μg of purified recombinant GAPDH. In some
experiments, 100 μM non-radioactive NAD+ or 100 μM non-radioactive
ADP-ribose was added as putative competitor. The effect of HgCl2 or
hydroxylamine (pH 7.4) on NAD+-dependent modification was determined
by incorporating these reagents at concentrations up to 5 mM into the reac-
tion buffer prior to the addition of [32P]NAD+. ADP-ribosylation reactions
were incubated for 1 h at 37°C followed by the addition of 25 μl of 4× SDS-
loading buffer to stop the reaction. The samples were heated to 70°C for 20
min and subjected to 12% SDS-PAGE [8]. The gel was dried and autoradio-
graphed at –80°C. 
Western blot. Western blot analysis using specific antibodies against E. coli
GAPDH was carried out as described previously [5].
Two-dimensional gel electrophoresis. 2D gel electrophoresis was
performed using the Protean IEF-Cell (Bio-Rad). Appropriate volumes of
protein samples were diluted in 125 μl of rehydration buffer (9 M urea, 4%
CHAPS, 50 mM DTT, 0.5% immobilized pH gradient buffer, and traces of
bromophenol blue). Isoelectric focusing was carried out in immobilized pH
5–8 gradient strips (BioRad). Second-dimension SDS-PAGE was done on
12.5% acrylamide gels. 
Mass spectrometry of proteins. Following SDS-PAGE [8], the gels
were stained and the protein bands of interest excised and digested with
trypsin (Sequencing grade modified, Promega) in the automatic Investigator
ProGest robot of Genomic Solutions. Peptides released from the gel were
analyzed by combined liquid chromatography/tandem mass spectrometry
(Cap-LC-nano-ESI-Q-TOF) (CapLC, Micromass-Waters) at the Scientific-
Technical Services of the University of Barcelona. Data were generated in
PKL file format, which were submitted for database searching in the MAS-
COT server.
DNA manipulation and site-directed mutagenesis. DNA
manipulations in vitro were carried out according to standard protocols [18].
Site-directed mutagenesis was done using the QuickChange PCR-based
mutagenesis procedure (Stratagene) with pGEX-GapA [5] as the template.
The primers used to construct the GAPDH C149A mutant were gapdh-mut1-
fw (5′-GTTTCCAACGCTTCCGCTACCACCAACTGCCTG-3′) and gapdh-
mut2-rv (5′-CAGGCAGTTGGTGGTAGCGGAAGCGTTGGAA AC-3′).
To construct C153A, the mutant primers were gapdh-mut2-fw (5′-CCTGCA
CCACCAACGCT CTGGCTCC GCTGGC-3′) and gapdh-mut2-rv (5′-GCC
AGCGGAGCCAGAGCGTTGGTGGT GCAGG-3′), and for C288A
mutant, gapdh-mut3-fw (5′-GATTTCAACGGCGAAGTTGCTACTTCCG
TGTTCG-3′) and gapdh-mut3-rv (5′-CGAACACGGAAGTAGCAACTTC
GCCGTTG AAATC-3′). The mutated codons are underlined. The appropri-
ate substitutions and the absence of mutations were confirmed by sequenc-
ing the inserts in both directions. 
Results and Discussion
Identification of GAPDH as an ADP-ribosylated
protein in Escherichia coli. To identify secreted pro-
teins that could be ADP-ribosylated in EHEC or EPEC strains,
cell-free supernatants of EHEC strain 86-24h11 or EPEC
strain E2348/69 [5] grown in DMEM were concentrated by
ammonium sulfate precipitation. These samples were incubat-
ed under ADP-ribosylation conditions and processed as
described in Materials and methods. Two protein bands, of 35
and 72 kDa, were radiolabeled in these conditions (Fig. 1A,
lanes 1 and 4). The presence of non-radioactive NAD+ inhib-
ited the labeling of both proteins (Fig. 1A, lanes 2 and 5)
whereas non-radioactive ADP-ribose did not modify the
ADP-ribosylation signal (Fig. 1A, lanes 3 and 6). These
results indicate that the covalent modification of both pro-
teins depends on NAD+.
The same 35 and 72 kDa protein bands were visualized
when the ADP-ribosylation reactions were carried out with
cell extracts of EHEC, indicating that these proteins are also
modified in the intracellular medium (Fig. 1B). The fact that
these results hold true for cell extracts of the non-pathogenic
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strains ECL1 [9] and EcoR26 [12] suggested that this modifi-
cation affects proteins expressed in all E. coli strains (Fig. 1B).
In all experiments done with cell extracts, the labeled pro-
teins appeared as fainter bands, which can be attributed to the
presence of intracellular ADP-ribosylhydrolases, as des-
cribed in other prokaryotes [15]. Likewise, when EHEC-
secreted protein samples were incubated at 37°C with the
corresponding cytoplasmic fraction in [32P]ADP-ribosylation
reaction mixtures, the radioactivity incorporated into the 35
and 72 kDa proteins was significantly reduced (not shown).
This suggests that in vivo NAD+-dependent modification of
these proteins can be blunted by intracellular factors.
The finding that the labeled 35 kDa protein was absent in
cell extracts of the gapA mutant strain W3CG [6] suggested
that GAPDH was one of the protein targets of post-transla-
tional modification by NAD+ (Fig. 1B). This was further sup-
ported by the results of Western blot analysis of ADP-ribosy-
lation reactions carried out with cell-free supernatants of
EHEC. A 35-kDa protein band coincident with that labeled in
the presence of [32P]NAD+ was detected with specific anti-
bodies against GAPDH (Fig. 1C, lane 2). To confirm the
identity of the 35-kDa protein as GAPDH, non-radioactive
ADP-ribosylation samples were electrophoresed in parallel
and the protein band coincident with the radioactive signal
was excised from a silver-stained duplicate gel (Fig. 1C, lane 3),
digested with trypsin, and analyzed by mass spectrometry.
This allowed the identification of several peptides belonging
all to E. coli GAPDH (Fig. 1D). 









Fig. 1. ADP-ribosylation of E. coli proteins. (A) Autoradiograph of ADP-ribosylation reactions carried out with the secreted protein fraction of
EHEC or EPEC strains following the standard protocol (lanes 1 and 4) or in the presence of a 50-fold molar excess of non-radioactive NAD+
(lanes 2 and 5) or ADP-ribose (lanes 3 and 6) as competitors. (B) Autoradiograph of ADP-ribosylation reactions done with cell extracts of the
indicated strains. EHEC reactions were also performed in the presence of a 50-fold molar excess of non-radioactive NAD+ (lane 2) or ADP-ribose
(lane 3). (C) ADP-ribosylated secreted protein samples of EHEC were analyzed by autoradiography (lane 1), by Western blotting with anti-
GAPDH specific antibodies (lane 2), or by silver staining (lane 3). The arrow indicates the 35-kDa protein band identified by mass spectrometry
as gapA-encoded GAPDH. (D) The peptides identified by mass spectrometry are indicated in bold over the GAPDH amino acid sequence. 
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To examine whether E. coli GAPDH is able to promote
its own modification, as described for the GAPDH of other
organisms [15], recombinant GAPDH was incubated with
[32P]NAD+ under ADP-ribosylation conditions. As shown in
Fig. 2A, the purified enzyme showed radioactive labeling,
which clearly diminished in the presence of non-radioactive
NAD+. In a previous study, the results of two-dimensional
(2D) gel electrophoresis analysis of recombinant GAPDH
showed that there are multiple forms of GAPDH which dif-
fer in their pI [5]. Here, a similar 2D-analysis was done with
GAPDH incubated under ADP-ribosylation conditions. The
gels were dried and either autoradiographed at –80°C or
processed for anti-GAPDH Western blotting. Parallel gels
were silver-stained to visualize total protein. Results of this
2D analysis showed that the ADP-ribosylated form corre-
sponded to a minor spot displaying the lowest pI (Fig. 2B).
Identification of Cys-149 as the amino acid
acceptor of the NAD+-dependent modification.
In an attempt to identify which residue was modified by
NAD+, ADP-ribosylation reactions were carried out in the
presence of increasing concentrations (0–5 mM) of hydroxy-
lamine (which inhibits Arg-specific ADP-ribosylation), or
HgCl2 (which inhibits Cys-specific ADP-ribosylation) [15].
The presence of hydroxylamine did not affect the radioactivity
incorporated into recombinant GAPDH, whereas HgCl2 inhib-
ited 32P-incorporation in a dose-dependent manner (Fig. 3A).
The same result was obtained when the secreted protein frac-
tion was used as a substrate in the ADP-ribosylation reaction
(not shown). These results suggest that the NAD+-dependent
modification of E. coli GAPDH occurred through a thiol
linkage to a Cys residue. To test this hypothesis, competitive
inhibition of GAPDH ADP-ribosylation was carried out in
the presence of an excess of free L-Cys, L-Arg or L-His,
which are ADP-ribose acceptors. Consistently, GAPDH
labeling in the presence of [32P]NAD+ was only inhibited by
L-Cys and this inhibition was dose-dependent (Fig. 3B).
Inhibition by L-Cys was also observed with the secreted pro-
tein (not shown). 
There are three Cys residues in E. coli GAPDH, Cys-149,
Cys-153, and Cys-288. To identify which of these residues
was the target of the NAD+-dependent modification, each
Cys residue was changed to Ala. The mutated proteins were
expressed and purified as described for the wild-type protein
[5] and then incubated with [32P]NAD+ under ADP-ribosyla-
tion conditions. Mutations C153A or C288A did not impair
radioactive incorporation into the protein, whereas mutation
C149A abolished NAD+-dependent labeling (Fig. 3C). These
results clearly pointed to the active-site Cys-149 as the target










Fig. 2. ADP-ribosylation of recombinant GAPDH. (A) Autoradiograph of
ADP-ribosylation reactions done with purified E. coli GAPDH following the
standard protocol (lane 1) or in the presence of a 50-fold molar excess of
non-radioactive NAD+ (lane 2) or ADP-ribose (lane 3). (B) Two-dimension-
al gel analysis of ADP-ribosylated GAPDH. Gels were processed for autora-
diography (upper strip), silver staining (middle strip) or Western blotting
with specific anti-GAPDH antibodies (bottom strip). 
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Since ADP-ribosylation is involved in signal transduction
events, our results point to additional roles for extracellular
GAPDH in the interaction of EHEC and EPEC strains with
the host, as proposed for other pathogens [1,15]. Moreover,
since this reversible NAD+-dependent modification also
takes place in the cytoplasm of pathogenic and non-patho-
genic E. coli strains, GAPDH may also play a regulatory role
within E. coli cells under physiological conditions. 
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